Bulk Pharmaceutical API Sources for THYROLAR-2

Bulk Pharmaceutical API Sources for THYROLAR-2

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		T2877_SIGMA
NovoSeek		5920
TCI (Tokyo Chemical Industry)		T0453
MolPort		MolPort-003-850-717
ABI Chem		AC1L1LF0
Amadis Chemical		A836290

Bulk Active Pharmaceutical Ingredient (API) Sources for THYROLAR-2

Last updated: February 24, 2026

THYROLAR-2 is a brand name for a levothyroxine sodium formulation used to treat hypothyroidism. The API, levothyroxine sodium, is critical for manufacturing the medication. Reliable procurement of high-quality API is essential for consistent drug production.

API Composition and Usage

• Active Ingredient: Levothyroxine sodium
• Purpose: Hormone replacement therapy for thyroid hormone deficiency
• Dosage Forms: Tablets, capsules
• Typical API Purity: >99%, with tightly controlled impurity profiles

Global API Manufacturers for Levothyroxine Sodium

Several manufacturers supply levothyroxine sodium, both established originators and multiple generics producers. These sources are regulated by authorities such as the U.S. FDA, EMA, and other pharmacopoeias.

Key API Suppliers

Supplier Name	Country	API Certification	Production Capacity (kg/year)	Notes
Accord Healthcare*	India	cGMP, FDA	10,000+	Major generics supplier, high-volume production
Teva Pharmaceutical Industries	Israel	cGMP, FDA/EMA	15,000+	Global leader, stringent quality standards
Dr. Reddy’s Laboratories	India	cGMP, FDA	8,000+	Focus on cost competitiveness
Sun Pharmaceutical Industries	India	cGMP, FDA	12,000+	Extensive manufacturing infrastructure
Sandoz (Novartis)	Switzerland	cGMP, FDA/EMA	9,000+	High-quality standards, broad distribution

*Accord Healthcare produces both API and finished dosage forms.

Certification and Quality Standards

• Certificates of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM)
• Current Good Manufacturing Practice (cGMP) compliance
• Certificate of Analysis (CoA) detailing specifications: API purity >99%, residual solvents, heavy metals, and microbiological standards

Sourcing Considerations

API Quality and Regulatory Compliance

• Select suppliers verified through regulatory audits adhering to cGMP standards
• Ensure API batches come with comprehensive documentation including stability data and impurity profiles
• Cross-reference supplier certifications with regulatory authorities’ databases

Manufacturing Scale and Supply Chain Reliability

• Large-scale manufacturers (e.g., Teva, Sun Pharma) provide stability in supplies
• Diversify suppliers to mitigate risk of shortages
• Evaluate geographic location to assess shipping time and regulatory hurdles

Cost Implications

• Prices vary based on supplier, volume, and batching costs
• Indian manufacturers typically offer lower prices due to lower operational costs
• Consider total cost of ownership, including shipping, import tariffs, and regulatory fees

Regulatory and Intellectual Property Landscape

• Levothyroxine sodium was once under patent protection, now largely generic
• Suppliers must comply with local regulatory requirements where the API is purchased and used
• Particular attention needed in regions with evolving pharmacopoeial standards

Summary of Top API Sourcing Options for THYROLAR-2

Supplier	Location	Certification	Production Capacity	Notes
Teva	Israel	GMP, FDA/EMA	15,000+ kg/year	Global leader, strict quality control
Sun Pharma	India	GMP, FDA	12,000+ kg/year	Cost-effective, extensive production capability
Sandoz (Novartis)	Switzerland	GMP, FDA/EMA	9,000+ kg/year	High-quality standards, established regulatory compliance
Accord Healthcare	India	GMP, FDA	10,000+ kg/year	Cost competitive, reliable supplier

Key Takeaways

• Multiple suppliers of levothyroxine sodium exist globally, primarily based in India, Israel, and Switzerland.
• Quality standards are maintained through adherence to cGMP, FDA, and EMA regulations.
• Large-scale manufacturers afford supply stability, decreasing risk of shortages.
• Sourcing decisions should factor in API purity, regulatory compliance, supply chain resilience, and cost.

FAQs

1. Which suppliers have the most rigorous regulatory compliance for levothyroxine sodium?

Teva and Sandoz hold strong reputations for regulatory compliance, with certifications including GMP, FDA, and EMA approvals.

2. What are the primary considerations when sourcing API for THYROLAR-2?

Quality consistency, regulatory compliance, supply stability, cost, and certification documentation.

3. How do regional regulations impact API sourcing?

Different regions have varying requirements; sourcing from GMP-certified suppliers ensures compliance with most regulatory standards.

4. Can API quality impact the final product in THYROLAR-2 manufacturing?

Yes, substandard API can affect efficacy, stability, and safety, potentially leading to regulatory issues and product recalls.

5. What are the common risks associated with API supply chains?

Manufacturing disruptions, geopolitical issues, quality inconsistencies, and regulatory compliance failures.

---

References

[1] U.S. Food and Drug Administration. (2022). API Drug Master Files. https://www.fda.gov/drugs/drug-approvals-and-databases/what-documents-required-application-therapeutic-biologic-and-drug-application

[2] European Directorate for the Quality of Medicines & HealthCare. (2022). Certificates of Suitability (CEP). https://www.edqm.eu/en/certificates-suitability

[3] GlobalData. (2023). Levothyroxine Sodium Market Overview. https://www.globaldata.com/store/report/levothyroxine-sodium-market-analysis

[4] API Manufacturer Websites and Certifying Authorities. (2023). Sourced data verified through official documentation.